Kappa-CD28 T Lymphocytes

· Baylor College of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Kappa-CD28 T Lymphocytes, covering 2025-10-21 to 2025-10-21. Get the full timeline:

Most recent: Clinical Trial Update: Kappa-CD28 T Lymphocytes, Chronic Lymphocytic Leukemia, B-cell Lymphoma or Multiple Myeloma, CHARKALL [Phase 1]